Open | - |
Close | - |
Volume / Avg. | 0 / 1.183M |
Day Range | - - - |
52 Wk Range | 12.350 - 62.210 |
Market Cap | $4.633B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 61 |
Short Interest | 8.91% |
Days to Cover | 8.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Biohaven (NYSE: BHVN) was reported by HC Wainwright & Co. on Monday, March 4, 2024. The analyst firm set a price target for 63.00 expecting BHVN to rise to within 12 months (a possible 12.50% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Biohaven (NYSE: BHVN) is $56 last updated March 18, 2024 at 5:08 PM EDT.
There are no upcoming dividends for Biohaven.
Biohaven’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.